27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
- Italian diagnostics firm DiaSorin SpA (OTC:DSRLF) has agreed to acquire Luminex Corporation (NASDAQ:LMNX) for $37 per share in an all-cash transaction, corresponding to a total equity value of approximately $1.8 billion.
- The offer price represents around 23.1% premium to Luminex shareholders based on the unaffected closing stock price of Luminex on 24 February (the date before press rumors regarding a potential sale of the company).
- Luminex makes COVID-19 laboratory tests along with a suite of other biological testing technologies.
- In March, it applied to the FDA for emergency approval of a lab test that combines tests for COVID-19 and the flu.
- The acquisition will broaden DiaSorin’s positioning in the molecular diagnostics space gaining access to Luminex’s molecular diagnostics multiplexing technology and a more significant foothold in the U.S. market.
- Following the acquisition, the new entity will have a combined 2020 revenue of approximately €1.25 billion, adjusted EBITDA of roughly €472 million, and a favorable net financial position of about €335 million.
- The transaction will be funded through a mix of cash and external financing. It’s expected to close in the third quarter.
- DiaSorin also signed a $1.1 billion term loan due in 2026 and a $500 million bridge loan due within 12 months with a group of banks including BNP, Citi, Mediobanca, and UniCredit.
- Price Action: LMNX shares gained 10.8% at $36.5, whiles DSRLF shares are up 0.49% at $165.81 in premarket trading on the last check Monday.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!